Charles Schwab’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Charles Schwab’s Portfolio VIE Stock Details VIE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-120,116	Closed	-$4.32M	–	3538
2020 Q4	$4.32M	Buy	120,116 +449	+0.4%	+$15.7K	﹤0.01%	2296
2020 Q3	$3.36M	Buy	119,667 +22,648	+23%	+$801K	﹤0.01%	2270
2020 Q2	$4.2M	Buy	97,019 +51,333	+112%	+$2.32M	﹤0.01%	2104
2020 Q1	$1.74M	Buy	45,686 +715	+2%	+$27.9K	﹤0.01%	2322
2019 Q4	$1.22M	Buy	+44,971	New	+$1.13M	﹤0.01%	2538

Charles Schwab's VIE Position: Q1 2021 in Review

Charles Schwab sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 120,116 shares — an estimated $4.32M sold.

Charles Schwab first reported a position in VIE in Q4 2019 and held it in 5 quarters. The position peaked at $4.32M in Q4 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

Charles Schwab reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Charles Schwab sold 120,116 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $4.32M.
Charles Schwab first reported a position in Viela Bio, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
Charles Schwab's Viela Bio, Inc. Common Stock position peaked at $4.32M in Q4 2020.
0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on Charles Schwab's 13F filing for Q1 2021, filed 17 May 2021.